Filing Flows › Abeona Therapeutics (ABEO) › R&D spending
Abeona Therapeutics (ABEO) R&D spending by quarter
Abeona Therapeutics' R&D spending was $5.0M in Q2 2026 (second quarter 2026), -47% from Q1 2026. Over the last 4 quarters it ranged from $5.0M (Q2 2026) to $9.6M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $5.0M | -47% | -16% |
| Q1 2026 | $9.6M | +42% | — |
| Q4 2025 | $6.7M | +13% | — |
| Q2 2025 | $5.9M | — | — |
Q2 2026 at a glance
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Abeona Therapeutics' R&D spending?
Abeona Therapeutics' R&D spending was $5.0M in Q2 2026 (second quarter 2026), -47% from Q1 2026.
How has Abeona Therapeutics' R&D spending changed?
Over the last 4 quarters it ranged from $5.0M (Q2 2026) to $9.6M (Q1 2026).